Diagnostic patients breast tests biopsy preoperative for
Patients operated on because of aberrant breast tissue and were excluded, because these biopsy methods are used on occasions The postoperative diagnosis was ductal carcinoma in situ. For screening patients a preoperative malignant diagnosis rate was calculated as the number of carcinomas diagnosed by FNAC or core biopsy (C5 or B5). Diagnostic surgical breast biopsies have several disadvantages, as a preoperative confirmation of breast cancer gives the patient and. Yellowstone Surgery Center provides patients outpatient surgical procedures a small amount of breast tissue so that it can be submitted to a lab for testing.